Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 20/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 18/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 11/20 | 0.49 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13930380 | 0.85 | DRD2 (0.43) | HDAC6HDAC8HDAC1 | |
| SCHEMBL4557277 | 0.78 | DGAT1 (0.49) | HDAC6HDAC8HDAC1HDAC5 | |
| SCHEMBL31675210 | 0.76 | HDAC6 (0.53) | HDAC6HDAC8HDAC1HDAC5 | |
| SCHEMBL14918111 | 0.74 | HDAC6 (0.63) | HDAC6HDAC8HDAC1HDAC5 | |
| SCHEMBL4443503 | 0.74 | DRD2 (0.43) | — | |
| SCHEMBL14918816 | 0.72 | HDAC6 (0.58) | HDAC6HDAC8HDAC1HDAC5 | |
| Trifluoroacetic Acid SCHEMBL31675215 | 0.71 | HDAC6 (0.51) | HDAC6HDAC8HDAC1HDAC5 | |
| SCHEMBL23711202 | 0.71 | HDAC4 (0.58) | HDAC6HDAC8HDAC1HDAC5 | |
| SCHEMBL14918283 | 0.70 | HDAC4 (0.58) | HDAC6HDAC8HDAC1HDAC5 | |
| SCHEMBL14932797 | 0.70 | HDAC6 (0.62) | HDAC6HDAC8HDAC1HDAC5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009037542-A2 | SPIROCYCLIC COMPOUNDS AS STEAROYL COA DESATURASE INHIBITORS | GLENMARK PHARMACEUTICALS, S.A. (US) | 2009-03-26 | — | — | WO | disclosed |
| WO-2009037542-A2 | SPIROCYCLIC COMPOUNDS AS STEAROYL COA DESATURASE INHIBITORS | GLENMARK PHARMACEUTICALS, S.A. (US) | 2009-03-26 | — | — | WO | disclosed |